CANNABIS POLAND AB ZY-10 - Asset Resilience Ratio

Latest as of December 2025: 57.87%

CANNABIS POLAND AB ZY-10 (8TE) has an Asset Resilience Ratio of 57.87% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CANNABIS POLAND AB ZY-10 (8TE) flexibility index to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

€1.74 Million

≈ $2.04 Million USD Cash + Short-term Investments

Total Assets

€3.01 Million

≈ $3.52 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2023–2025)

This chart shows how CANNABIS POLAND AB ZY-10's Asset Resilience Ratio has changed over time. See CANNABIS POLAND AB ZY-10 net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down CANNABIS POLAND AB ZY-10's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CANNABIS POLAND AB ZY-10 stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€1.74 Million	57.87%
Total Liquid Assets	€1.74 Million	57.87%

Asset Resilience Insights

Very High Liquidity: CANNABIS POLAND AB ZY-10 maintains exceptional liquid asset reserves at 57.87% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

CANNABIS POLAND AB ZY-10 Industry Peers by Asset Resilience Ratio

Compare CANNABIS POLAND AB ZY-10's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for CANNABIS POLAND AB ZY-10 (2023–2025)

The table below shows the annual Asset Resilience Ratio data for CANNABIS POLAND AB ZY-10.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	57.87%	€1.74 Million ≈ $2.04 Million	€3.01 Million ≈ $3.52 Million	-16.04pp
2024-12-31	73.90%	€3.09 Million ≈ $3.62 Million	€4.19 Million ≈ $4.90 Million	+10.44pp
2023-12-31	63.46%	€1.16 Million ≈ $1.36 Million	€1.84 Million ≈ $2.15 Million	--

pp = percentage points

About CANNABIS POLAND AB ZY-10

F:8TE Germany Drug Manufacturers - Specialty & Generic

Market Cap

$1.82 Million

€1.56 Million EUR

Market Cap Rank

#30215 Global

#2654 in Germany

Share Price

€0.03

Change (1 day)

-5.45%

52-Week Range

€0.02 - €0.07

All Time High

€0.69